Provided by Tiger Trade Technology Pte. Ltd.

Hillenbrand

31.98
0.0000
Volume:- -
Turnover:- -
Market Cap:2.25B
PE:52.46
High:31.98
Open:31.98
Low:31.98
Close:31.98
52wk High:32.07
52wk Low:22.98
Shares:70.51M
Float Shares:69.85M
Volume Ratio:1.68
T/O Rate:- -
Dividend:0.90
Dividend Rate:2.81%
EPS(TTM):0.6096
EPS(LYR):0.6096
ROE:3.12%
ROA:2.73%
PB:1.63
PE(LYR):52.46

Loading ...

Ling Yui bolsters board with HI Group co-founders as new executive directors

TIPRANKS
·
May 11

Press Release: Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients

GlobeNewswire
·
May 06

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

GlobeNewswire
·
May 02

Apex Securities Starts HI Mobility at Buy with MYR2.73 Price Target

MT Newswires Live
·
Apr 29

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

GlobeNewswire
·
Apr 21

SUPER HI Earnings Call Balances Growth With Margin Strain

TIPRANKS
·
Apr 05

Boston Scientific Reports Strong HI-PEITHO Trial Results for EKOS

TIPRANKS
·
Mar 30

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

GlobeNewswire
·
Mar 24

Jakarta Police Urge Firecracker-Free Eid Eve Celebrations

Tempo
·
Mar 20

Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting

GlobeNewswire
·
Mar 10

Rezolute to Participate in the Citizens Life Sciences Conference

GlobeNewswire
·
Mar 04

Press Release: Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Mar 03

Astec to Debut TerraSource Equipment at CONEXPO‑CON/AGG 2026

Reuters
·
Mar 02